Tempest Therapeutics financial statements

템페스트 테라퓨틱스NASDAQ:TPST · Nasdaq · Healthcare · sector #13
$0.7926-2.29%
2026-10-05 close

Tempest Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$42M.

Reported results

Tempest Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q